Prosecution Insights
Last updated: April 19, 2026
Application No. 17/145,092

CATHETER WITH BRAID AND RADIOPAQUE SECTION

Non-Final OA §102§103§112
Filed
Jan 08, 2021
Examiner
DOUBRAVA, JOHN A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Surmodics, Inc.
OA Round
5 (Non-Final)
76%
Grant Probability
Favorable
5-6
OA Rounds
3y 2m
To Grant
99%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allow Rate
229 granted / 300 resolved
+6.3% vs TC avg
Strong +26% interview lift
Without
With
+26.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
26 currently pending
Career history
326
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
44.3%
+4.3% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
28.0%
-12.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 300 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on November 6, 2025 has been entered. Response to Amendment This office action is responsive to the amendment filed on November 6, 2025. As directed by the amendment: claims 8, 13, 18 and 29 have been amended, claims 1-7, 9, 17 and 26-28 have been cancelled, and no claims have been added. Thus, claims 8, 10-16, 18-25 and 29-31 are presently pending in this application. Applicant’s amendments are sufficient to overcome the claim objection and the §112(a) and §112(b) rejections of the previous action. Response to Arguments Applicant’s arguments, see Remarks, filed November 6, 2025, with respect to the rejections of claims 8, 10-25 and 29-31 under 35 U.S.C. §112(a) and with respect to the rejections of claims 8 and 10-25 under 35 U.S.C. §112(b) have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Chouinard US 2004/0176740 A1. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 10 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 10 lines 2-3 recites that the second braid profile is rotationally offset from the first braid profile to rotationally offset the first filar array from the second filar array…”. Claim 8, from which claim 10 depends, lines 6-7 recite “…the first braid profile is a tubular shape…”, and claim 8 lines 12-13 recite “…the second braid profile is a second tubular shape…”. It is not clear how a tubular shape can be rotationally offset. Additionally, it is not clear how braid profiles are related to offset the first filar array from the second filar array because those filar arrays only make up the first braid profile. Additionally, claim 10 lines 4-5 recite braid profiles relative to the longitudinal axis. It is not clear how braid profiles which are tubular shapes have angles relative to the catheter longitudinal axis. No art has been applied to claim 10 because it is not clear how a tubular shape can be rotationally offset. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 8, 12-16, 18-25 and 29-31 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chouinard US 2004/0176740 A1. Regarding claim 8, Chouinard discloses a catheter assembly (intraluminal delivery system 1, P0025), comprising: a catheter body (sheath 2, shown in Figs. 3-6, wherein the braid of Fig. 5a overlays the braid of Fig. 5b as described in P0043, wherein the braid of Fig. 5a has a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer that provides a sheath with greater longitudinal compressive stiffness) extending from a catheter proximal portion to a catheter distal portion (catheter proximal portion toward the hub end, and catheter distal portion toward the tip end); a first braided metal layer (braid layer 9 of Fig. 5b, metal P0046) within the catheter body, wherein: the first braided metal layer includes at least a first filar array (strands 14 P0042 wound clock-wise as shown in Fig. 5b) and a second filar array (strands 14 P0042 wound counter clock-wise as shown in Fig. 5b), and the first filar array is interlaced with the second filar array (Fig. 5b, and braid configuration of P0039); and the first braided metal layer has a first braid profile, and the first braid profile is a tubular shape (Fig. 6); a second braided metal layer (braid layer 8 of Fig. 5a, metal P0046) coupled along an exterior of the first braided metal layer (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer), wherein: the second braided metal layer includes at least a third filar array (strands 13 P0042 wound clock-wise as shown in Fig. 5a) and a fourth filar array (strands 13 P0042 wound counter clock-wise as shown in Fig. 5a), and the third filar array is interlaced with the fourth filar array (Fig. 5a, and braid configuration of P0039); and the second braided metal layer has a second braid profile, and the second braid profile is a second tubular shape (Fig. 6); and wherein the first braided metal layer and the second braided metal layer are configured to expand to an expanded configuration with application of an axial force along a catheter longitudinal axis (radially expanded configuration results from longitudinal compression of the sheath), and in the expanded configuration: the first braided metal layer is configured to expand at a first rate (due to braid angle 12), the first braided metal layer being within the second braided metal layer (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer); and the second braided metal layer is configured to expand at a second rate less than the first rate of expansion (due to braid angle 11 being greater than braid angle 12), and the second braided metal layer is configured to constrain and brace the first braided metal layer (the dissimilarity of the angles of the braid layers create resistance to relative movement radially, P0043). Regarding claim 12, Chouinard discloses the catheter assembly of claim 8, wherein the second braided metal layer constrains and braces the first braided metal layer and minimizes kinking of the catheter body (greater longitudinal compressive stiffness from the dissimilarity of the angles of the braid layers create resistance to relative movement radially, P0043). Regarding claim 13, Chouinard discloses a catheter assembly (intraluminal delivery system 1, P0025), comprising: a catheter body (sheath 2, shown in Figs. 3-6, wherein the braid of Fig. 5a overlays the braid of Fig. 5b as described in P0043, wherein the braid of Fig. 5a has a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer that provides a sheath with greater longitudinal compressive stiffness) extending from a catheter proximal portion to a catheter distal portion (catheter proximal portion toward the hub end, and catheter distal portion opposite the proximal portion) having a distal tip (distal tip 5, P0026); a first braided metal layer (braid layer 9 of Fig. 5b, metal P0046) within the catheter body, wherein: the first braided metal layer includes a first braided profile and the first braided profile is a tubular shape (Fig. 6); and the first braided metal layer includes at least a first filar array (strands 14 P0042 wound clock-wise as shown in Fig. 5b) and a second filar array (strands 14 P0042 wound counter clock-wise as shown in Fig. 5b), and the first filar array is interwoven with the second filar array (Fig. 5b, and braid configuration of P0039); a second braided metal layer (braid layer 8 of Fig. 5a, metal P0046) coupled along an exterior of the first braided metal layer (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer), wherein: the second braided metal layer includes a second braided profile and the second braided profile is a second tubular shape (Fig. 6), wherein the first braided metal layer is within the second braided metal layer; and the second braided metal layer includes at least a third filar array (strands 13 P0042 wound clock-wise as shown in Fig. 5a) and a fourth filar array (strands 13 P0042 wound counter clock-wise as shown in Fig. 5a), and the third filar array is interwoven with the fourth filar array (Fig. 5a, and braid configuration of P0039); and wherein the first braided metal layer and the second braided metal layer are configured to expand to an expanded configuration with application of an axial force along a catheter longitudinal axis (radially expanded configuration results from longitudinal compression of the sheath), and in the expanded configuration: the first braided metal layer is configured to expand at a first rate (due to braid angle 12), the first braided metal layer being within the second braided metal layer; and the second braided metal layer is configured to expand at a second rate less than the first rate of expansion (due to braid angle 11 being greater than braid angle 12), and the second braided metal layer is configured to constrain and brace the first braided metal layer (the dissimilarity of the angles of the braid layers create resistance to relative movement radially, P0043). Regarding claim 14, Chouinard discloses the catheter assembly of claim 13, wherein the first filar array includes a first filar and a second filar, and the first filar is spaced apart from the second filar by a first interstitial space (see annotated Figs. 5a-b below). PNG media_image1.png 870 582 media_image1.png Greyscale Regarding claim 15, Chouinard discloses the catheter assembly of claim 14, wherein the second filar array includes a third filar and a fourth filar, and the third filar is spaced apart from the fourth filar by a second interstitial space (see annotated Figs. 5a-b above). Regarding claim 16, Chouinard discloses the catheter assembly of claim 15, wherein: the first filar and the second filar have a first orientation (clock-wise); the third filar and the fourth filar have a second orientation (counter clock-wise); and the first orientation is different than the second orientation. Regarding claim 18, Chouinard discloses the catheter assembly of claim 15, wherein at least a first portion of the first interstitial space is coincident with at least a second portion of the second interstitial space in correspondence with the first filar array interwoven with the second filar array (see annotated Figs. 5a-b above). Regarding claim 19, Chouinard discloses the catheter assembly of claim 18, wherein: the third filar array includes a fifth filar and a sixth filar, and the fifth filar is spaced apart from the sixth filar by a third interstitial space; the fourth filar array includes a seventh filar and an eighth filar, and the seventh filar is spaced apart from the eighth filar by a fourth interstitial space; at least a third portion of the third interstitial space is coincident with at least a fourth portion of the fourth interstitial space in correspondence with the third filar array interwoven with the fourth filar array (see annotated Figs. 5a-b above). Regarding claim 20, Chouinard discloses the catheter assembly of claim 19, wherein: the first filar and the second filar have a first orientation (clock-wise); the third filar and the fourth filar have a second orientation (counter clock-wise); the first orientation is different than the second orientation; the fifth filar and the sixth filar have a third orientation (clock-wise); the seventh filar and the eighth filar have a fourth orientation (counter clock-wise); and the third orientation is different than the fourth orientation. Regarding claim 21, Chouinard discloses the catheter assembly of claim 20, wherein one or more of the first orientation or the second orientation are different than one or more of the third orientation or the fourth orientation (see claim 21 above). Regarding claim 22, Chouinard discloses the catheter assembly of claim 19, wherein the first filar and the second filar of the first filar array and the third filar and the fourth filar of the second filar array are located radially inwards of the fifth filar and the sixth filar of the third filar array and the seventh filar and the eighth filar of the fourth filar array (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer). Regarding claim 23, Chouinard discloses the catheter assembly of claim 22, wherein the fifth filar and the sixth filar of the third filar array and the seventh filar and the eighth filar of the fourth filar array extend along exteriors of the first filar and the second filar of the first filar array and of the third filar and the fourth filar of the second filar array (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer). Regarding claim 24, Chouinard discloses the catheter assembly of claim 23, wherein the first filar and the second filar of the first filar array and the third filar and the fourth filar of the second filar array are not interwoven with the fifth filar and the sixth filar of the third filar array and the seventh filar and the eighth filar of the fourth filar array (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer). Regarding claim 25, Chouinard discloses the catheter assembly of claim 23, wherein the first braided metal layer is not interwoven with the second braided metal layer (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer). Regarding claim 29, Chouinard discloses a catheter assembly (intraluminal delivery system 1, P0025), comprising: a catheter body (sheath 2, shown in Figs. 3-6, wherein the braid of Fig. 5a overlays the braid of Fig. 5b as described in P0043, wherein the braid of Fig. 5a has a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer that provides a sheath with greater longitudinal compressive stiffness) extending from a catheter proximal portion to a catheter distal portion (catheter proximal portion toward the hub end, and catheter distal portion toward the tip end); a first braided metal layer (braid layer 9 of Fig. 5b, metal P0046) within the catheter body, wherein: the first braided metal layer includes at least a first filar array (strands 14 P0042 wound clock-wise as shown in Fig. 5b) and a second filar array (strands 14 P0042 wound counter clock-wise as shown in Fig. 5b), and the first filar array is interlaced with the second filar array (Fig. 5b, and braid configuration of P0039); and the first braided metal layer has a first braid profile, and the first braid profile is a tubular shape (Fig. 6); a second braided metal layer (braid layer 8 of Fig. 5a, metal P0046) coupled along an exterior of the first braided metal layer (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer), wherein: the second braided metal layer includes at least a third filar array (strands 13 P0042 wound clock-wise as shown in Fig. 5a) and a fourth filar array (strands 13 P0042 wound counter clock-wise as shown in Fig. 5a), and the third filar array is interlaced with the fourth filar array (Fig. 5a, and braid configuration of P0039); and the second braided metal layer has a second braid profile, and the second braid profile is a second tubular shape (Fig. 6) with the first braided metal layer within the second tubular shape (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer, and P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer); and wherein: the first braided metal layer and the second braided metal layer are configured to expand to an expanded configuration with an application of axial force along a catheter longitudinal axis (radially expanded configuration results from longitudinal compression of the sheath), and in the expanded configuration: the first braided metal layer is configured to expand at a first rate (due to braid angle 12); and the second braided metal layer is configured to expand at a second rate less than the first rate of expansion (due to braid angle 11 being greater than braid angle 12), and the expansion at the second rate is configured to constrain and brace the first braided metal layer (the dissimilarity of the angles of the braid layers create resistance to relative movement radially, P0043); (see annotated Figs. 5a-c below for the following limitations) the first filar array includes a first filar and a second filar, and the first filar is spaced apart from the second filar by a first interstitial space; the second filar array includes a third filar and a fourth filar, and the third filar is spaced apart from the fourth filar by a second interstitial space; the third filar array includes a fifth filar and a sixth filar, and the fifth filar is spaced apart from the sixth filar by a third interstitial space; the fourth filar array includes a seventh filar and an eighth filar, and the seventh filar is spaced apart from the eighth filar by a fourth interstitial space; at least a first portion of the first interstitial space is coincident with at least a second portion of the second interstitial space in correspondence with the first filar array interlaced with the second filar array; and at least a third portion of the third interstitial space is coincident with at least a fourth portion of the fourth interstitial space in correspondence with the third filar array interlaced with the fourth filar array. PNG media_image1.png 870 582 media_image1.png Greyscale Regarding claim 30, Chouinard discloses the catheter assembly of claim 29, wherein: the first filar and the second filar have a first orientation (clock-wise); the third filar and the fourth filar have a second orientation; (counter clock-wise) the first orientation is different than the second orientation; the fifth filar and the sixth filar have a third orientation (clock-wise); the seventh filar and the eighth filar have a fourth orientation (counter clock-wise); and the third orientation is different than the fourth orientation. Regarding claim 31, Chouinard discloses the catheter assembly of claim 29, wherein: the interlaced filars of the third filar array and the fourth filar array extend along an exterior of the interlaced filars of the first filar array and the second filar array (sheath 2 of P0043 and shown in Figs. 5a-b, having a smaller braid angle 12 layer circumferentially covered by a larger braid angle 11 layer); and the interlaced filars of the first filar array and the second filar array are not interlaced with the interlaced filars of the third filar array and the fourth filar array (P0045-0046 describe the method of making, wherein the second braid layer is slid over the first braid layer). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Chouinard in view of Stigall et al. (Stigall) US 2014/0058257 A1. Regarding claim 11, Chouinard discloses the catheter assembly of claim 8. Chouinard does not teach the catheter assembly further comprising: a coil proximate to the catheter distal portion, the coil having a first section and a second section, wherein: the first section of the coil extends toward a distal tip, and the first section has a first imaging characteristic; the second section is swaged and extends from the first section to the distal tip, and the second section of the coil has a second imaging characteristic, and the distal tip includes the second section of the coil; and the second imaging characteristic differs from the first imaging characteristic, and the first imaging characteristic and second imaging characteristics are configured to contrast and emphasize visibility of the distal tip relative to a remainder of the catheter body. However, Stigall teaches a catheter body (body 510, P0055) comprising: a coil (coil 120, P0056) proximate to the catheter distal portion (distal shaft portion 545 includes the marker coil 120, P0056), the coil having a first section (loosely wound section 160, P0063) and a second section (tightly wound section 155, P0063), wherein: the first section of the coil extends toward a distal tip (see annotated Fig. 14 below), and the first section has a first imaging characteristic (less radiopacity, P0038); the second section is swaged (Fig. 10 showing the coil swaged) and extends from the first section to the distal tip (see annotated Fig. 14 below), and the second section of the coil has a second imaging characteristic (greater radiopacity, P0038), and the distal tip includes the second section of the coil (see annotated Fig. 14 below); and the second imaging characteristic differs from the first imaging characteristic (coil 120 forms blocks of greater radiopacity or radiodensity than the loosely wound sections 160, see P0039-0040), and the first imaging characteristic and second imaging characteristics are configured to contrast and emphasize visibility of the distal tip relative to a remainder of the catheter body (P0038 and Fig. 14). PNG media_image2.png 758 1004 media_image2.png Greyscale It would have been obvious to one having ordinary skill in the art before the effective filing date of the invention to modify the catheter assembly of Chouinard with the coil of Stigall for the purpose of visualizing the progress of the catheter assembly towards the target location within a patient’s body, as taught by Stigall P0003. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN A DOUBRAVA whose telephone number is (408)918-7561. The examiner can normally be reached M-F 9-5 Pacific Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /J.A.D./Examiner, Art Unit 3783 /James D Ponton/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jan 08, 2021
Application Filed
Sep 02, 2023
Non-Final Rejection — §102, §103, §112
Jan 08, 2024
Response Filed
Apr 18, 2024
Final Rejection — §102, §103, §112
Aug 27, 2024
Examiner Interview Summary
Aug 27, 2024
Applicant Interview (Telephonic)
Aug 30, 2024
Response after Non-Final Action
Sep 10, 2024
Response after Non-Final Action
Sep 10, 2024
Examiner Interview (Telephonic)
Sep 30, 2024
Request for Continued Examination
Oct 05, 2024
Response after Non-Final Action
Nov 21, 2024
Non-Final Rejection — §102, §103, §112
Apr 29, 2025
Response Filed
Aug 05, 2025
Final Rejection — §102, §103, §112
Oct 29, 2025
Interview Requested
Nov 05, 2025
Applicant Interview (Telephonic)
Nov 06, 2025
Request for Continued Examination
Nov 06, 2025
Examiner Interview Summary
Nov 16, 2025
Response after Non-Final Action
Feb 27, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582803
CATHETER TIP CONTROL DEVICE AND RELATED SYSTEMS AND METHODS
2y 5m to grant Granted Mar 24, 2026
Patent 12582580
SET DETECTION AND FLOW MONITORING SYSTEM
2y 5m to grant Granted Mar 24, 2026
Patent 12575771
SYRINGE FOR OBTAINING A TARGET VOLUME OF BLOOD
2y 5m to grant Granted Mar 17, 2026
Patent 12569679
TREATMENT DELIVERY SYSTEM
2y 5m to grant Granted Mar 10, 2026
Patent 12569647
Catheter Support Apparatus and Transluminal Intervention System
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
76%
Grant Probability
99%
With Interview (+26.3%)
3y 2m
Median Time to Grant
High
PTA Risk
Based on 300 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month